The objective of this study was to estimate the risk of contralateral breast cancer in BRCA1 and BRCA2 carriers; and measure the extent to which host, family history, and cancer treatment-related ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback